We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Industry Insights

Will the Potential of Proteomics Be Realized in 2020?
Industry Insight

Technology Networks recently spoke with Stephen Williams, CMO at biotechnology company SomaLogic, to learn more about research progress in the proteomics space and the technology that has enabled it.

Read More

Making Diagnostic Testing More Accessible
Industry Insight

Technology Networks spoke with Erik Allen, Vice President and General Manager, Specimen Management for BD, to learn more about the advantages of capillary collection and the importance of making diagnostic testing more convenient and comfortable for patients.

Read More

Driving Medical Innovation To Improve the Lives of Patients
Industry Insight

Technology Networks recently spoke with LifeArc’s CEO Melanie Lee, PhD, CBE. Melanie elaborates on LifeArc's mission, discusses the importance of bridging the gap between "bench" and "bedside", and highlights how genomics can help drive earlier intervention.

Read More

Drug Candidate for Lung Cancer Receives FDA Fast Track Designation
Industry Insight

Technology Networks spoke with Rodney Varner, CEO of Genprex, to learn more about the next steps for Oncoprex, a lead drug candidate that treats non-small cell lung cancer, and how the FDA Fast Track Designation will facilitate the delivery of this drug to cancer patients.

Read More

Efforts To Sequence the Coronavirus Continue As New Gene Sequencer Is Launched in Asia
Industry Insight

Technology Networks spoke with GenapSys to learn more about the sequencer which is "100x smaller and less expensive than legacy high-throughput sequencers" and how it can be applied to study the Coronavirus.

Read More

Delving Into Glycogen Storage Diseases
Industry Insight

In this interview, Gaia Fancellu, of Iceni Diagnostics, talks about her work in more detail, discusses the challenges of studying GSDs, and highlights the advantages of using a “Systems Medicine” approach to do so.

Read More

Reducing Errors in Whole Genome Sequencing: It Starts With Library Prep
Industry Insight

The highly complex process of whole genome sequencing comes with a high cost of error. One pipetting or mixing mistake can lead to costly errors downstream. When working with multiple samples, error-free sample handling and proper mixing becomes even more critical. The first step in the process to prepare the sample for sequencing, library prep, is a vital step that, if not done correctly, can lead to flawed data and costly delays.

Read More

Detecting the Presence of Cancer in Patients’ Breath
Industry Insight

Thermo Fisher Scientific and Owlstone Medical have recently entered a collaboration, with the aim of advancing breath diagnostics for the early diagnosis of cancer and other diseases. Dr Max Allsworth, Chief Science Officer, Owlstone Medical, and Dominic Roberts, Product Marketing Manager, Orbitrap GC-MS, Thermo Fisher Scientific tell us more about the collaboration and the advantages that breath biopsies can bring to disease detection.

Read More

Using Protein Biomarkers Increases the Chances of Success in Clinical Trials
Industry Insight

Many clinical trials fail due to lack of efficacy. But while some of this may be due to poor target selection during the drug discovery process, it’s becoming increasingly clear that only certain patients respond to treatments. So how exactly does precision medicine increase the likelihood of success in clinical trials?

Read More

Simplifying Next-generation Sequencing in the Clinic
Industry Insight

We recently spoke to Luca Quagliata, Ph.D., Global Head of Medical Affairs for Clinical NGS and Oncology at Thermo Fisher Scientific, to discuss some of the barriers preventing full adoption of NGS-based genomic testing in hospitals, and learn more about a solution that can help to address these.

Read More

 
Advertisement